Vanda Pharmaceuticals
Develops and commercializes specialty therapies across psychiatric, sleep, MS, and motion-sickness markets.
$5.29
After-hours close0.00 (0.00%)
At close$5.29(−2.76%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.72 | — | — |
| Aug 2026 | −$0.58 | −$1.04 | −78.5% |
| May 2026 | −$0.53 | −$0.82 | −54.7% |
| Feb 2026 | −$2.18 | −$0.46 | +78.9% |
| Oct 2025 | −$0.31 | −$0.38 | −22.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.72 | — | — | $69.3M | — | — |
| Aug 5, 2026 | −$0.58 | −$1.04 | −78.5% | $61.9M | $50.5M | −18.4% |
| May 6, 2026 | −$0.53 | −$0.82 | −54.7% | $55.0M | $51.7M | −5.9% |
| Feb 11, 2026 | −$2.18 | −$0.46 | +78.9% | $59.3M | $57.2M | −3.5% |
| Oct 29, 2025 | −$0.31 | −$0.38 | −22.6% | $59.3M | $56.3M | −5.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 31, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 13, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Jul 31, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 7, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Jul 27, 2023 | ||||||
| May 3, 2023 | ||||||
| Feb 8, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 23, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Jul 28, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 10, 2021 | ||||||
| Oct 28, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Jul 31, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 13, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 1, 2018 | ||||||
| May 2, 2018 | ||||||
| Feb 14, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 2, 2017 | ||||||
| Feb 15, 2017 | ||||||
| Nov 2, 2016 | ||||||
| Jul 27, 2016 | ||||||
| May 4, 2016 | ||||||
| Feb 10, 2016 | ||||||
| Nov 3, 2015 | ||||||
| Jul 29, 2015 | ||||||